Categories AlphaGraphs, Earnings, Health Care
Johnson & Johnson (JNJ) Q2 2024 Earnings: Key financials and quarterly highlights
Johnson & Johnson (NYSE: JNJ) reported its second quarter 2024 earnings results today.
Reported sales increased 4.3% year-over-year to $22.4 billion. Operational sales growth was 6.6%.
Net income decreased 12.8% to $4.6 billion while EPS dropped 5.9% to $1.93. Adjusted EPS rose 10.2% to $2.82.
Revenue and earnings beat estimates.
For the full year of 2024, JNJ expects reported sales of $88.0-88.4 billion and adjusted EPS of $9.97-10.07.
The stock was down over 1% in premarket hours on Wednesday.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Kroger’s Q3 report likely to reflect consumer caution amid macro headwinds
The Kroger Co. (NYSE: KR) is preparing to report third-quarter results this week while navigating a challenging market environment. In the first half, the grocery chain's performance was not very
Estee Lauder (EL): A look at the challenges weighing down this beauty giant
Shares of The Estée Lauder Companies Inc. (NYSE: EL) rose over 2% on Monday. The stock has dropped 19% over the past three months. The beauty company had a disappointing
Hormel Foods (HRL) to report Q4 2024 earnings results, a look at what to expect
Shares of Hormel Foods Corporation (NYSE: HRL) rose over 1% on Friday. The stock has gained over 5% in the past one month. The branded food company is slated to
